Signaturefd LLC Lowers Stock Position in Tilray Inc (NASDAQ:TLRY)

Signaturefd LLC reduced its holdings in Tilray Inc (NASDAQ:TLRY) by 3.3% during the 4th quarter, Holdings Channel reports. The fund owned 195,735 shares of the company’s stock after selling 6,673 shares during the period. Signaturefd LLC’s holdings in Tilray were worth $450,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in TLRY. Clear Street Markets LLC purchased a new stake in shares of Tilray in the 3rd quarter valued at $25,000. Lake Street Financial LLC purchased a new stake in shares of Tilray in the 3rd quarter valued at $28,000. Great Valley Advisor Group Inc. purchased a new stake in shares of Tilray in the 3rd quarter valued at $29,000. Stratos Wealth Advisors LLC purchased a new stake in shares of Tilray in the 3rd quarter valued at $31,000. Finally, Simplicity Solutions LLC purchased a new stake in shares of Tilray in the 3rd quarter valued at $32,000. 9.35% of the stock is owned by hedge funds and other institutional investors.

Tilray Price Performance

TLRY opened at $1.84 on Thursday. The company has a quick ratio of 1.18, a current ratio of 1.92 and a debt-to-equity ratio of 0.11. Tilray Inc has a 52-week low of $1.50 and a 52-week high of $3.40. The firm’s fifty day simple moving average is $1.95 and its two-hundred day simple moving average is $1.95.

Analyst Ratings Changes

A number of brokerages recently issued reports on TLRY. CIBC lowered their price target on shares of Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a report on Wednesday, April 10th. Canaccord Genuity Group lowered their price target on shares of Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Finally, Alliance Global Partners increased their price target on shares of Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a report on Friday, April 5th.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.